Most Recent
A proposal by Bristol-Myers Squibb-owned Celgene to split a second trial into two more hearings in a dispute over patents covering the pharmaceutical maker's top selling cancer drug Revlimid would result in wasted costs, wasted time and require a second judge, a court has been told.
A Sydney law firm that brought a class action against Boston Scientific over allegedly defective pelvic mesh products has agreed to stay its case while a class action by Shine Lawyers moves ahead.
Merck Sharp & Dohme has filed a lawsuit accusing rival drug company Bristol-Myers Squibb of misusing its market power by restricting access to a treatment program for stage IV melanoma patients.
A former managing director of global drug giant Apotex is suing his old employer over $226,000 in bonuses and $175,000 in leave he claims were not paid when he was made redundant in September 2019.
A judge has allowed a key US-based witness in ASIC's case against former Quintis director Frank Wilson who will not submit to 14 days in hotel quarantine to give evidence by video link.
Monash IVF patients who accuse the company of destroying viable embryos are having "second thoughts" after accepting payment offers by the fertility clinic and signing away their rights to participate in a class action, a Victoria Supreme Court judge has heard.
Two Melbourne-based aged care providers want negligence claims that are unrelated to COVID-19 removed from class actions over their handling of the pandemic, in a move that may exclude a “very large number” of group members from the proceedings.
The Australian Competition and Consumer Commission has taken legal action against international dental care company Smile Direct Club for allegedly misleading tens of thousands of consumers with claims they would be eligible for private health insurance coverage for their aligner teeth straighteners.
Victorian public healthcare provider Peninsula Health has hit back at an underpayments class action brought by junior doctors, saying it was up to them to seek authorisation and payment for any overtime hours worked.
The Full Federal Court has upheld US biotech company Sequenom's patent for a noninvasive prenatal genetic test, rejecting rival Ariosa Diagnostic's argument that the patent merely described a way to extract incorporeal genetic information.